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maternal age, race/ethnicity, education, parity, family income, smoking status, alcohol 
consumption, infant gender, mode of delivery, gestational age at serum collection, and total 
serum PCB concentrations. P trend was obtained by using the median value in each quartile as a 







Table S1. Comparison of published studies on polybrominated diphenyl ether and thyroid hormone levels in pregnancy.a 
First Author, Year Study 
Size 
Time of Sampling (weeks of 
gestation) 
PBDEs TSH TT4 TT3 FT4 FT3 
  PBDEs THs       












 260 10±3 Delivery  NS ↓ (BDE-99) ↓ (∑PBDEs, 
BDE-47)c 
↓ (BDE-99)c ↓ (∑PBDEs, 
BDE-47) 
 260 10±3 Cord Serum  NS ↓ (∑PBDEs, 
BDE-47, -99) 
NS ↓ (∑PBDEs, 
BDE-47, -99) 
− 
Vuong et al., (current 
study)d 





NS ↑ (BDE-28, -47) ↑ (BDE-47) ↑ (BDE-28, -47) ↑ (BDE-28, -47) 
 256 16±3 Cord Serum  NS NS NS NS ↓ (BDE-28) 









NS − NS − 





↓ NS − NS − 





BDE-47, -99, -100) 
↑(BDE-47) ↑ (∑PBDEs, 
BDE-47, -153) 
NS 








First Author, Year Study 
Size 
Time of Sampling (weeks of 
gestation) 
PBDEs TSH TT4 TT3 FT4 FT3 
  PBDEs THs       




− NS NS NS NS 
 9 Cord Serum Cord Serum  − NS NS NS NS 
Herbstman et al., 2008d 289 Cord Serum Cord Serum BDE-47  
BDE-100  
BDE-153 
NS ↓ (BDE-100)f − NS − 




NS − − NS − 
Zhang et al., 2010g 50 Cord Serum 16 ∑PBDEs NS NS NS − − 






NS − NS ↓ (BDE-28) − 








NS NS ↓ (BDE-154) NS ↓ (BDE-153, -183) 
Abbreviations: NS, not significant. 
a↑ represents an increase; ↓ represents a decrease; − represents not studied. bBDE-47 median >20 ng/g lipid. cFor volume-based models. dBDE-47 median 10-20 




Table S2. Coefficients of variation for thyroid hormone and antibody assays. 
Thyroid hormone or antibody Concentration Coefficient of  
Variation (%) 
TSH (uIU/mL) 0.7 5.8 
 29.1 5.2 
TT4 (µg/dL) 5.1 6.9 
 19.3 4.7 
TT3 (ng/dL) 83.7 7.3 
 270.6 3.6 
FT4 (ng/dL) 0.6 <1.0 
 4.8 5.9 
FT3 (pg/mL) 2.1 10.0 
 8.9 6.1 
TPOAb (IU/mL) 6.1 11.0 
 56.1 9.3 
TgAb (IU/mL) 4.6 9.6 





Table S3. Thyroid hormone levels, HOME Study.a 
Thyroid Hormones and 
Antibodies 
Maternal Serum at 16 Weeks 
(n=187) 
Mean±SD or N (%) 
Cord Serum 
(n=256) 
TSHb 1.2±2.2 7.1±1.8 
TT4  10.3±1.9 9.6±1.8 
TT3  160.5±24.1 51.5±18.9 
FT4  0.7±0.1 1.0±0.2 
FT3  3.2±0.3 1.7±0.3 
TPOAb    
    Above the medianc 85(45.7) 118(46.6) 
TgAb    
    Detectable 66(35.5) 105(41.3) 
Abbreviations: SD, standard deviation. 
aTSH (uIU/mL), TT4 (µg/dL), TT3 and FT4 (ng/dL), FT3 (pg/mL), TPOAb and TgAb (IU/mL). bGeometric 





Table S4. Spearman rank correlation matrix for polybrominated diphenyl ether congeners and 
thyroid hormones, HOME Study.a 
Variable BDE-28 BDE-47 BDE-99 BDE-100 BDE-153 ∑PBDEs 
PBDEsb       
    BDE-28       
    BDE-47 0.87##      
    BDE-99 0.76## 0.92##     
    BDE-100 0.78## 0.90## 0.85##    
    BDE-153 0.50## 0.50## 0.47## 0.74##   
    ∑PBDEs 0.83## 0.92## 0.88## 0.96## 0.73##  
Thyroid hormonesc       
    Maternal Serum       
        TSH  -0.04 -0.09 -0.10 -0.02 -0.04 -0.05 
        TT4  0.16* 0.19* 0.18* 0.12 -0.02 0.13 
        TT3  0.16* 0.25# 0.23** 0.21** 0.03 0.19* 
        FT4  0.18* 0.17* 0.10 0.10 0.02 0.12 
        FT3  0.18* 0.26# 0.18* 0.15 -0.01 0.18* 
    Cord Serum       
        TSH  -0.07 -0.13* -0.20** -0.09 0.03 -0.13 
        TT4  -0.02 -0.02 -0.01 -0.02 0.06 -0.02 
        TT3  -0.12 -0.10 -0.08 -0.08 0.03 -0.08 
        FT4 -0.05 -0.01 0.02 -0.01 -0.001 -0.03 
        FT3  -0.12 -0.08 -0.06 -0.07 0.01 -0.08 
 
*p<0.05, **p<0.01, #p<0.001, ##p<0.0001. 
aUnits: PBDE (ng/g lipid), TSH (uIU/mL), TT4 (µg/dL), TT3 and FT4 (ng/dL), and FT3 (pg/mL). bTotal n 
for each of the pairwise correlations with BDE-28, -47, -99, -100, -153, and ∑PBDEs ranged from 274 to 
294. cTotal n for each of the pairwise correlations with thyroid hormones ranged from 166 to 187 for 




Table S5. Spearman rank correlation matrix for thyroid hormone levels in maternal and cord sera, HOME Study.a 
Thyroid  Maternal Serum Cord Serum 
Hormones TSH TT4 TT3 FT4 FT3 TSH TT4 TT3 FT4 FT3 
Maternal Serum           
    TSH           
    TT4 -0.16*          
    TT3 0.04 0.49**         
    FT4 -0.19** 0.48** 0.08        
    FT3 0.07 0.34** 0.69** 0.20**       
Cord Serum           
    TSH 0.26** -0.12 0.10 -0.13 0.06      
    TT4 0.04 0.02 0.06 -0.09 -0.06 -0.06     
    TT3 0.004 -0.09 0.11 -0.17* 0.07 0.12 0.38**    
    FT4 -0.01 -0.02 0.09 -0.02 -0.03 -0.10 0.58** 0.19**   
    FT3 -0.04 0.004 0.11 -0.11 0.06 0.09 0.31** 0.74** 0.23**  
 
*p<0.05, **p<0.01 






Table S6. Adjusted associations between maternal polybrominated diphenyl ether concentrations 
and maternal and cord sera levels of thyroid antibodies, HOME Study.a 
Thyroid Antibodies Maternal Serumb 
β (95% CI) 
Cord Serumb,c 
β (95% CI) 
TPOAb   
    BDE-28 -0.61 (-1.29, 0.07) -0.11 (-0.65, 0.43) 
    BDE-47 -0.49 (-1.09, 0.10) -0.08 (-0.56, 0.40) 
    BDE-99 -0.45 (-1.02, 0.11) -0.24 (-0.71, 0.22) 
    BDE-100 -0.25 (-0.82, 0.32) -0.12 (-0.57, 0.33) 
    BDE-153 -0.0001 (-0.53, 0.53) -0.23 (-0.67, 0.21) 
    ∑PBDEs -0.27 (-0.89, 0.34) -0.15 (-0.65, 0.34) 
TgAb   
    BDE-28 0.07 (-0.35, 0.50) -0.02 (-0.45, 0.40) 
    BDE-47 0.17 (-0.21, 0.54) -0.01 (-0.38, 0.37) 
    BDE-99 0.16 (-0.20, 0.51) 0.05 (-0.31, 0.42) 
    BDE-100 0.08 (-0.27, 0.44) -0.03 (-0.38, 0.33) 
    BDE-153 -0.004 (-0.34, 0.33) -0.001 (-0.35, 0.34) 
    ∑PBDEs 0.12 (-0.26, 0.51) -0.03 (-0.42, 0.35) 
Only includes individuals with complete information for the PBDE exposure and covariates. 
aUnits: PBDEs (ng/g lipid), TPOAb and TgAb (IU/mL). PBDEs were log10-transformed and thyroid 
antibodies were log-transformed. bAdjusted for maternal age, race/ethnicity, education, parity, family 
income, smoking status, alcohol consumption, gestational age at blood draw, and total serum PCB 




Table S7. Associations between polybrominated diphenyl ether concentrations and select thyroid 
hormones in maternal and cord sera by thyroid antibody levels, HOME Study.a,b 
Thyroid Hormones by 







β (95% CI) 
PBDEs with  
TPOAb>median or 
TgAb≥LODd 
β (95% CI) 
Maternal Serume    
lnTSH    
    TPOAb×BDE-28 0.596 -0.15 (-0.57, 0.28) 0.04 (-0.51, 0.59) 
    TPOAb×BDE-47 0.466 -0.23 (-0.59, 0.14) -0.01 (-0.47, 0.46) 
    TPOAb×BDE-99 0.253 -0.25 (-0.59, 0.10) 0.07 (-0.37, 0.52) 
    TPOAb×BDE-100 0.294 -0.22 (-0.57, 0.14) 0.09 (-0.36, 0.54) 
    TPOAb×BDE-153 0.227 -0.26 (-0.63, 0.11) 0.07 (-0.30, 0.45) 
    TPOAb×∑PBDEs 0.165 -0.28 (-0.66, 0.10) 0.16 (-0.33, 0.64) 
    TgAb×BDE-28 0.895 -0.06 (-0.45, 0.34) -0.11 (-0.78, 0.56) 
    TgAb×BDE-47 0.495 -0.18 (-0.51, 0.14) 0.06 (-0.57, 0.68) 
    TgAb×BDE-99 0.249 -0.19 (-0.49, 0.12) 0.21 (-0.41, 0.84) 
    TgAb×BDE-100 0.656 -0.13 (-0.45, 0.18) 0.02 (-0.57, 0.60) 
    TgAb×BDE-153 0.377 -0.03 (-0.34, 0.28) -0.28 (-0.74, 0.19) 
    TgAb×∑PBDEs 0.391 -0.18 (-0.51, 0.16) 0.15 (-0.51, 0.80) 
TT4    
    TPOAb×BDE-28 0.521 1.09 (0.09, 2.10) 0.56 (-0.75, 1.87) 
    TPOAb×BDE-47 0.802 0.94 (0.08, 1.81) 0.77 (-0.33, 1.87) 
    TPOAb×BDE-99 0.501 0.71 (-0.13, 1.54) 0.25 (-0.81, 1.31) 
    TPOAb×BDE-100 0.616 0.72 (-0.13, 1.56) 0.37 (-0.72, 1.45) 
    TPOAb×BDE-153 0.258 0.44 (-0.45, 1.33) -0.30 (-1.20, 0.60) 
    TPOAb×∑PBDEs 0.461 0.86 (-0.05, 1.78) 0.31 (-0.85, 1.47) 
    TgAb×BDE-28 0.498 0.71 (-0.22, 1.65) 1.35 (-0.22, 2.93) 
    TgAb×BDE-47 0.935 0.91 (0.14, 1.68) 0.84 (-0.62, 2.31) 
    TgAb×BDE-99 0.446 0.69 (-0.05, 1.42) 0.05 (-1.44, 1.55) 
    TgAb×BDE-100 0.888 0.57 (-0.18, 1.32) 0.46 (-0.95, 1.86) 
    TgAb×BDE-153 0.998 0.03 (-0.72, 0.77) 0.02 (-1.10, 1.15) 
    TgAb×∑PBDEs 0.675 0.71 (-0.09, 1.51) 0.34 (-1.23, 1.90) 
TT3    
    TPOAb×BDE-28 0.350 12.89 (0.91, 24.87) 3.54 (-12.08, 19.17) 
    TPOAb×BDE-47 0.281 12.34 (2.01, 22.68) 3.32 (-9.81, 16.45) 
    TPOAb×BDE-99 0.075* 11.80 (1.94, 21.66) -2.35 (14.87, 10.17) 
    TPOAb×BDE-100 0.632 8.57 (-1.51, 18.65) 4.60 (-8.29, 17.49) 
    TPOAb×BDE-153 0.590 -0.86 (-11.51, 9.80) 3.35 (-7.42, 14.12) 
    TPOAb×∑PBDEs 0.420 9.40 (-1.56, 20.36) 2.17 (-11.64, 15.98) 
    TgAb×BDE-28 0.686 8.43 (-2.64, 19.49) 12.93 (-5.72, 31.58) 
    TgAb×BDE-47 0.676 8.62 (-0.53, 17.77) 12.76 (-4.61, 30.12) 
    TgAb×BDE-99 0.897 7.42 (-1.23, 16.07) 6.16 (-11.43, 23.75) 
    TgAb×BDE-100 0.670  5.93 (-2.94, 14.79) 9.96 (-6.54, 26.45) 
    TgAb×BDE-153 0.865 0.22 (-8.60, 9.03) 1.59 (-11.68, 14.85) 




Thyroid Hormones by 







β (95% CI) 
PBDEs with  
TPOAb>median or 
TgAb≥LODd 
β (95% CI) 
FT4    
    TPOAb×BDE-28 0.959 0.05 (0.002, 0.10) 0.05 (-0.02, 0.11) 
    TPOAb×BDE-47 0.786 0.04 (-0.004, 0.08) 0.05 (-0.01, 0.10) 
    TPOAb×BDE-99 0.831 0.02 (-0.02, 0.06) 0.03 (-0.02, 0.08) 
    TPOAb×BDE-100 0.931 0.03 (-0.02, 0.07) 0.02 (-0.03, 0.08) 
    TPOAb×BDE-153 0.492 0.02 (-0.03, 0.06) -0.01 (-0.05, 0.04) 
    TPOAb×∑PBDEs 0.814 0.03 (-0.01, 0.08) 0.03 (-0.03, 0.08) 
    TgAb×BDE-28 0.159 0.03 (-0.02, 0.08) 0.10 (0.02, 0.17)  
    TgAb×BDE-47 0.048* 0.02 (-0.01, 0.06) 0.11 (0.03, 0.18) 
    TgAb×BDE-99 0.258 0.01 (-0.02, 0.05) 0.06 (-0.01, 0.14) 
    TgAb×BDE-100 0.220 0.01 (-0.03, 0.05) 0.06 (-0.01, 0.13) 
    TgAb×BDE-153 0.855 0.001 (-0.04, 0.04) 0.01 (-0.05, 0.06) 
    TgAb×∑PBDEs 0.213 0.02 (-0.02, 0.06) 0.07 (-0.004, 0.15) 
FT3    
    TPOAb×BDE-28 0.890 0.13 (-0.02, 0.28) 0.15 (-0.05, 0.34) 
    TPOAb×BDE-47 0.977 0.12 (-0.01, 0.25) 0.12 (-0.05, 0.28) 
    TPOAb×BDE-99 0.370 0.11 (-0.02, 0.23) 0.02 (-0.14, 0.18) 
    TPOAb×BDE-100 0.878 0.07 (-0.06, 0.20) 0.08 (-0.08, 0.25) 
    TPOAb×BDE-153 0.753 -0.01 (-0.15, 0.12) 0.02 (-0.12, 0.15) 
    TPOAb×∑PBDEs 0.827 0.11 (-0.03, 0.25) 0.08 (-0.09, 0.26) 
   
    TgAb×BDE-28 0.307 0.10 (-0.04, 0.24) 0.24 (0.004, 0.48) 
    TgAb×BDE-47 0.090* 0.08 (-0.04, 0.19) 0.29 (0.07, 0.51) 
    TgAb×BDE-99 0.190 0.05 (-0.06, 0.16) 0.21 (-0.01, 0.44) 
    TgAb×BDE-100 0.144 0.03 (-0.08, 0.15) 0.21 (-0.001, 0.42) 
    TgAb×BDE-153 0.489 -0.02 (-0.14, 0.09) 0.05 (-0.12, 0.22) 
    TgAb×∑PBDEs 0.134 0.06 (-0.07, 0.18) 0.26 (0.02, 0.49) 
Cord Serume,f    
lnTSH    
    TPOAb×BDE-28 0.218 0.07 (-0.18, 0.33) -0.18 (-0.48, 0.13) 
    TPOAb×BDE-47 0.166 0.03 (-0.19, 0.26) -0.20 (-0.46, 0.06) 
    TPOAb×BDE-99 0.371 -0.05 (-0.27, 0.17) -0.20 (-0.44, 0.04) 
    TPOAb×BDE-100 0.275 0.06 (-0.15, 0.28) -0.12 (-0.37, 0.13) 
    TPOAb×BDE-153 0.340 0.14 (-0.08, 0.35) -0.02 (-0.26, 0.22) 
    TPOAb×∑PBDEs 0.337 0.03 (-0.21, 0.26) -0.15 (-0.41, 0.12) 
    TgAb×BDE-28 0.165 0.07 (-0.18, 0.33) -0.22 (-0.55, 0.10) 
    TgAb×BDE-47 0.047* 0.02 (-0.19, 0.24) -0.34 (-0.63, -0.05) 
    TgAb×BDE-99 0.074* -0.06 (-0.26, 0.14) -0.36 (-0.65, -0.08) 
    TgAb×BDE-100 0.198 0.04 (-0.17, 0.25) -0.18 (-0.45, 0.09) 
    TgAb×BDE-153 0.136 0.17 (-0.05, 0.39) -0.09 (-0.34, 0.17) 
    TgAb×∑PBDEs 0.072* 0.04 (-0.18, 0.27) -0.30 (-0.61, 0.002) 
TT4    
    TPOAb×BDE-28 0.743 -0.03 (-0.88, 0.81) -0.26 (-1.31, 0.79) 
    TPOAb×BDE-47 0.792 -0.08 (-0.83, 0.67) -0.24 (-1.12, 0.65) 




Thyroid Hormones by 







β (95% CI) 
PBDEs with  
TPOAb>median or 
TgAb≥LODd 
β (95% CI) 
    TPOAb×BDE-100 0.656 -0.06 (-0.77, 0.66) -0.30 (-1.14, 0.53) 
    TPOAb×BDE-153 0.626 0.03 (-0.68, 0.75) -0.23 (-1.03, 0.56) 
    TPOAb×∑PBDEs 0.657 -0.04 (-0.82, 0.74) -0.31 (-1.22, 0.60) 
    TgAb×BDE-28 0.851 -0.19 (-1.03, 0.66) -0.06 (-1.13, 1.02) 
    TgAb×BDE-47 0.695 -0.08 (-0.79, 0.63) -0.31 (-1.28, 0.65) 
    TgAb×BDE-99 0.478 0.04 (-0.63, 0.71) -0.37 (-1.31, 0.58) 
    TgAb×BDE-100 0.819 -0.22 (-0.91, 0.47) -0.09 (-0.98, 0.80) 
    TgAb×BDE-153 0.366 -0.31 (-1.02, 0.41) 0.21 (-0.62, 1.03) 
    TgAb×∑PBDEs 0.944 -0.15 (-0.89, 0.59) -0.19 (-1.20, 0.82) 
TT3    
    TPOAb×BDE-28 0.998 -4.67 (-12.02, 2.67) -4.66 (-13.49, 4.17) 
    TPOAb×BDE-47 0.907 -3.14 (-9.65, 3.37) -3.72 (-11.26, 3.81) 
    TPOAb×BDE-99 0.924 -2.28 (-8.70, 4.14) -2.73 (-9.74, 4.28) 
    TPOAb×BDE-100 0.620 -2.75 (-8.99, 3.50) -0.36 (-7.50, 6.78) 
    TPOAb×BDE-153 0.616 2.96 (-3.25, 9.18) 0.58 (-6.28, 7.44) 
    TPOAb×∑PBDEs 0.807 -1.43 (-8.20, 5.34) -2.70 (-10.45, 5.05) 
    TgAb×BDE-28 0.159 -0.65 (-8.92, 7.62) -10.34 (-20.89, 0.21) 
    TgAb×BDE-47 0.371 0.13 (-6.88, 7.13) -5.16 (-14.68, 4.36) 
    TgAb×BDE-99 0.564 0.60 (-6.06, 7.26) -2.64 (-11.88, 6.61) 
    TgAb×BDE-100 0.744 0.12 (-6.74, 6.97) -1.74 (-10.57, 7.10) 
    TgAb×BDE-153 0.700 2.95 (-4.16, 10.06) 0.77 (-7.49, 9.03) 
    TgAb×∑PBDEs 0.426 1.26 (-6.04, 8.57) -3.71 (-13.66, 6.24) 
FT4    
    TPOAb×BDE-28 0.222 -0.01 (-0.07, 0.06) -0.07 (-0.15, 0.01) 
    TPOAb×BDE-47 0.188 0.004 (-0.06, 0.06) -0.06 (-0.12, 0.01) 
    TPOAb×BDE-99 0.349 0.02 (-0.04, 0.07) -0.02 (-0.09, 0.04) 
    TPOAb×BDE-100 0.161 0.003 (-0.05, 0.06) -0.06 (-0.12, 0.01) 
    TPOAb×BDE-153 0.123 0.005 (-0.05, 0.06) -0.06 (-0.12, 0.0001) 
    TPOAb×∑PBDEs 0.087* 0.005 (-0.06, 0.07) -0.08 (-0.14, -0.01) 
    TgAb×BDE-28 0.658 -0.03 (-0.09, 0.04) -0.05 (-0.14, 0.03) 
    TgAb×BDE-47 0.444 -0.02 (-0.07, 0.04) -0.05 (-0.13, 0.02) 
    TgAb×BDE-99 0.435 0.002 (-0.05, 0.06) -0.03 (-0.11, 0.04) 
    TgAb×BDE-100 0.665 -0.02 (-0.08, 0.03) -0.04 (-0.11, 0.03) 
    TgAb×BDE-153 0.893 -0.02 (-0.08, 0.03) -0.03 (-0.09, 0.04) 
    TgAb×∑PBDEs 0.269 -0.02 (-0.07, 0.04) -0.07 (-0.15, 0.01) 
FT3    
    TPOAb×BDE-28 0.654 -0.13 (-0.26, -0.001) -0.08 (-0.24, 0.07) 
    TPOAb×BDE-47 0.881 -0.08 (-0.20, 0.03) -0.07 (-0.20, 0.06) 
    TPOAb×BDE-99 0.961 -0.05 (-0.16, 0.06) -0.05 (-0.17, 0.08) 
    TPOAb×BDE-100 0.348 -0.09 (-0.20, 0.02) -0.01 (-0.13, 0.12) 
    TPOAb×BDE-153 0.716 -0.02 (-0.13, 0.09) 0.01 (-0.11, 0.13) 
    TPOAb×∑PBDEs 0.826 -0.08 (-0.20, 0.04) -0.06 (-0.19, 0.08) 
    TgAb×BDE-28 0.026* -0.01 (-0.14, 0.12) -0.26 (-0.42, -0.09) 
    TgAb×BDE-47 0.036* 0.01 (-0.10, 0.12) -0.19 (-0.34, -0.03) 




Thyroid Hormones by 







β (95% CI) 
PBDEs with  
TPOAb>median or 
TgAb≥LODd 
β (95% CI) 
    TgAb×BDE-100 0.199 0.01 (-0.10, 0.12) -0.11 (-0.25, 0.03) 
    TgAb×BDE-153 0.828 0.003 (-0.11, 0.12) -0.02 (-0.15, 0.12) 
    TgAb×∑PBDEs 0.076* 0.01 (-0.10, 0.13) -0.17 (-0.32, -0.01) 
*p value<0.10 
aUnits: PBDEs (ng/g lipid), TSH (uIU/mL), TT3 and FT4 (ng/dL), and FT3 (pg/mL), TPOAb and TgAb 
(IU/mL). PBDEs were log10-transformed. bMaternal and cord models used antibodies measured in their 
respective sera. For TgAb: c PBDEs with TgAb levels that were not detectable, d PBDEs with detectable 
TgAb levels. eAdjusted for maternal age, race/ethnicity, education, parity, family income, smoking status, 
alcohol consumption, gestational age at blood draw, and total serum PCB concentrations. fAdditionally 





Figure S1. β-coefficients and 95% CIs from regression models for associations of BDE-28 and 
BDE-47 (ng/g lipid) quartiles and thyroid hormones in cord serum. All models adjusted for 
maternal age, race/ethnicity, education, parity, family income, smoking status, alcohol 
consumption, infant gender, mode of delivery, gestational age at serum collection, and total 
serum PCB concentrations. P trend was obtained by using the median value in each quartile as a 
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